Related Experiment Video
Updated: Jul 13, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth
Francisco Verdeguer1, Claudia Castro, Markus Kubicek
1Laboratory of Vascular Biology, Department of Molecular and Cellular Pathology and Therapy, Instituto de Biomedicina de Valencia (IBV-CSIC), Spanish Council for Scientific Research, 46010 Valencia, Spain.
Insights
Hypercholesterolemia activates complement components (CCs), particularly C3 and C3a. This activation promotes vascular smooth muscle cell and macrophage proliferation, potentially contributing to atherosclerosis development.
Area of Science:
- Immunology
- Cardiovascular Biology
Background:
- Atherosclerosis is linked to complement system activation.
- Hypercholesterolemia is a major risk factor for atherosclerosis.
Purpose of the Study:
- Investigate complement component (CC) expression in hypercholesterolemia.
- Determine the effects of CCs on vascular smooth muscle cell (VSMC) and macrophage proliferation.
- Elucidate the molecular mechanisms of CC-mediated proliferation.
Main Methods:
- Analyzed mRNA and protein expression of CCs in hypercholesterolemic mice (apoE-KO) and human plasma (familial hypercholesterolemia patients).
- Conducted in vitro studies on VSMC and macrophage proliferation.
- Assessed CCs' role in proliferation via Gi protein-dependent ERK1/2 activation.
Main Results:
- Hypercholesterolemic apoE-KO mice and FH patients showed elevated CCs (C3, C4, C1s, C1q).
- C3 and C3a, but not other CCs, promoted VSMC and macrophage proliferation.
- C3/C3a mediated proliferation via Gi protein-dependent ERK1/2 activation.
Conclusions:
- Hypercholesterolemia triggers coordinated CC activation.
- C3/C3a drive VSMC and macrophage proliferation, suggesting a role in atheroma growth.
Objective:
Mounting evidence suggests that activation of complement, an important constituent of innate immunity, contributes to atherosclerosis. Here we investigated the expression of complement components (CCs) in the setting of experimental and clinical hypercholesterolemia, a major risk factor for atherosclerosis, their effects on vascular smooth muscle cell (VSMC) and macrophage proliferation, and the underlying molecular mechanisms.
Methods:
For this study we analyzed the mRNA and protein expression of several CCs in plasma and aorta of hypercholesterolemic atherosclerosis-prone apolipoprotein E-null mice (apoE-KO) and in plasma of normocholesterolemic subjects and familial hypercholesterolemia (FH) patients. We also carried out in vitro molecular studies to assess the role of CCs on the control of macrophage and VSMC proliferation.
Results:
Fat-fed apoE-KO mice experiencing severe hypercholesterolemia (approximately 400 mg/dL), but not fat-fed wild-type controls with plasma cholesterol level<110 mg/dL, displayed in aortic tissue upregulation of several CC mRNAs, including C3, C4, C1s, and C1q. In apoE-KO mice, induction of C3 mRNA was already apparent two days after fat feeding when hypercholesterolemia was manifested yet atherosclerotic lesions were absent or incipient. Rapid C3 and C4 protein upregulation was also observed in the plasma of fat-fed apoE-KO mice, and FH patients exhibited higher plasmatic C3a, C4 gamma chain, C1s and C3c alpha chain protein levels than normocholesterolemic subjects. In vitro, C3 and C3a, but not C3a-desArg, C4 and C1q, promoted macrophage and VSMC proliferation through Gi protein-dependent activation of extracellular signal-regulated kinase 1/2 (ERK1/2). We also found that C3-enriched FH plasma evoked a stronger mitogenic response in macrophages than normocholesterolemic plasma, and treatment with anti-C3 antibodies eliminated this difference.
Conclusions:
Both experimental and clinical hypercholesterolemia coincides with a concerted activation of several CCs. However, only C3 and C3a elicited a mitogenic response in cultured VSMCs and macrophages through Gi protein-dependent ERK1/2 activation. Thus, excess of C3/C3a in hypercholesterolemic apoE-KO mice and FH patients may contribute to atheroma growth by promoting neointimal cell proliferation.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inflammation
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Atherosclerosis III: Management
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

